Close

Apply Online


Medicine

ESCITALIN


In the treatment of Depression Associated Anxiety

  • Potent anxiolytic & antidepressant activity
  • Shows effect within 1 week as compared to 4 weeks with other selective serotonin reuptake inhibitors
  • Safe in cardiac patients & well tolerated for long term use
  • USFDA approved antidepressant

Indication


  MAJOR DEPRESSIVE DISORDER      GENERALIZED ANXIETY DISORDER        SOCIAL ANXIETY DISORDER  

  PANIC DISORDER  


Extremely selective & faster SSRI


Enquiry Now